review article communicationsupportforpeoplewithals

7
Hindawi Publishing Corporation Neurology Research International Volume 2011, Article ID 714693, 6 pages doi:10.1155/2011/714693 Review Article Communication Support for People with ALS David Beukelman, Susan Fager, and Amy Nordness Institute for Rehabilitation Science and Engineering Madonna Rehabilitation Hospital and University of Nebraska, 202 Barkley Memorial Center, P.O. Box 830732, Lincoln, NE 68583-0732, USA Correspondence should be addressed to David Beukelman, [email protected] Received 15 November 2010; Accepted 2 February 2011 Academic Editor: Peter van den Bergh Copyright © 2011 David Beukelman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Almost all people with amyotrophic lateral sclerosis (ALS) experience a motor speech disorder, such as dysarthria, as the disease progresses. At some point, 80 to 95% of people with ALS are unable to meet their daily communication needs using natural speech. Unfortunately, once intelligibility begins to decrease, speech performance often deteriorates so rapidly that there is little time to implement an appropriate augmentative and alternative communication (AAC) intervention; therefore, appropriate timing of referral for AAC assessment and intervention continues to be a most important clinical decision-making issue. AAC acceptance and use have increased considerably during the past decade. Many people use AAC until within a few weeks of their deaths. 1. Introduction Almost all people with amyotrophic lateral sclerosis (ALS) experience a motor speech disorder as the disease progresses. Initial symptoms typically do not interfere with speech intelligibility and may be limited to a reduction in speaking rate, a change in phonatory (voice) quality, or imprecise articulation. At some point in the disease progression, 80 to 95% of people with ALS are unable to meet their daily communication needs using natural speech. In time, most become unable to speak at all [1]. For them, communication support involves a range of augmentative and alternative communication (AAC) strategies involving low- and high- technology (speech generating device) options [2]. Clinical decision-making related to communication is quite complex as screening, referral, assessment, acquisition of technology, and training must occur in a timely manner, so when residual speech is no longer eective, AAC strategies are in place to support communication related to personal care, medical care, social interaction, community involvement, and perhaps employment. Although there is considerable research on the speech characteristics of people with ALS, it is the primary purpose of this paper to review the published research related to communication supports for people with ALS whose natural speech no longer meets their communication needs. 2. Speech Characteristics ALS involves both upper and lower motor neurons; there- fore, it results in mixed dysarthria of the flaccid-spastic type [3, 4]. In the early stages of ALS when dysarthria is mild, either spasticity or flaccidity is predominant. As ALS pro- gresses and dysarthria becomes severe, profound weakness resulting in reduced movement of the speech musculature and severely reduced phonation become increasingly com- mon [5, 9]. Changes in speech patterns or speaking rate typically occur before a decrease in speech intelligibility [69]. Initially, speaking rate gradually slows; however, speech intel- ligibility initially remains relatively high. In time, dysarthria becomes apparent to people with ALS and their listeners, and then speech intelligibility decreases such that commu- nication eectiveness is reduced at first in adverse speaking situations, such as noisy crowds, and then in all situations. The results of a study by Ball et al. [10] revealed that percep- tions of communication eectiveness for speakers with ALS were quite similar for the speakers and their frequent listeners

Upload: others

Post on 13-Nov-2021

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Review Article CommunicationSupportforPeoplewithALS

Hindawi Publishing CorporationNeurology Research InternationalVolume 2011, Article ID 714693, 6 pagesdoi:10.1155/2011/714693

Review Article

Communication Support for People with ALS

David Beukelman, Susan Fager, and Amy Nordness

Institute for Rehabilitation Science and Engineering Madonna Rehabilitation Hospital and University of Nebraska,202 Barkley Memorial Center, P.O. Box 830732, Lincoln, NE 68583-0732, USA

Correspondence should be addressed to David Beukelman, [email protected]

Received 15 November 2010; Accepted 2 February 2011

Academic Editor: Peter van den Bergh

Copyright © 2011 David Beukelman et al. This is an open access article distributed under the Creative Commons AttributionLicense, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properlycited.

Almost all people with amyotrophic lateral sclerosis (ALS) experience a motor speech disorder, such as dysarthria, as the diseaseprogresses. At some point, 80 to 95% of people with ALS are unable to meet their daily communication needs using natural speech.Unfortunately, once intelligibility begins to decrease, speech performance often deteriorates so rapidly that there is little time toimplement an appropriate augmentative and alternative communication (AAC) intervention; therefore, appropriate timing ofreferral for AAC assessment and intervention continues to be a most important clinical decision-making issue. AAC acceptanceand use have increased considerably during the past decade. Many people use AAC until within a few weeks of their deaths.

1. Introduction

Almost all people with amyotrophic lateral sclerosis (ALS)experience a motor speech disorder as the disease progresses.Initial symptoms typically do not interfere with speechintelligibility and may be limited to a reduction in speakingrate, a change in phonatory (voice) quality, or imprecisearticulation. At some point in the disease progression, 80to 95% of people with ALS are unable to meet their dailycommunication needs using natural speech. In time, mostbecome unable to speak at all [1]. For them, communicationsupport involves a range of augmentative and alternativecommunication (AAC) strategies involving low- and high-technology (speech generating device) options [2]. Clinicaldecision-making related to communication is quite complexas screening, referral, assessment, acquisition of technology,and training must occur in a timely manner, so whenresidual speech is no longer effective, AAC strategies are inplace to support communication related to personal care,medical care, social interaction, community involvement,and perhaps employment. Although there is considerableresearch on the speech characteristics of people with ALS,it is the primary purpose of this paper to review thepublished research related to communication supports for

people with ALS whose natural speech no longer meets theircommunication needs.

2. Speech Characteristics

ALS involves both upper and lower motor neurons; there-fore, it results in mixed dysarthria of the flaccid-spastic type[3, 4]. In the early stages of ALS when dysarthria is mild,either spasticity or flaccidity is predominant. As ALS pro-gresses and dysarthria becomes severe, profound weaknessresulting in reduced movement of the speech musculatureand severely reduced phonation become increasingly com-mon [5, 9].

Changes in speech patterns or speaking rate typicallyoccur before a decrease in speech intelligibility [6–9].Initially, speaking rate gradually slows; however, speech intel-ligibility initially remains relatively high. In time, dysarthriabecomes apparent to people with ALS and their listeners,and then speech intelligibility decreases such that commu-nication effectiveness is reduced at first in adverse speakingsituations, such as noisy crowds, and then in all situations.The results of a study by Ball et al. [10] revealed that percep-tions of communication effectiveness for speakers with ALSwere quite similar for the speakers and their frequent listeners

Page 2: Review Article CommunicationSupportforPeoplewithALS

2 Neurology Research International

across 10 different social situations. ALS speakers and theirlisteners reported a range of communication effectivenessdepending upon the adversity of specific social situations.

3. Speech Intervention

A recent review of ALS communication research [11]concluded that, because of the pathophysiology and thedegenerative nature of ALS, speech treatment strategiesthat are designed to increase strength or mobility of theoral musculature are not recommended. People with ALS,or those close to them, often request oral exercises toimprove strength and mobility for speech and swallowing,as strengthening exercises seem intuitive to them as wayto increase performance. However, such exercise programsshould be discouraged, and those with ALS should beinformed that the speaking that they do each day provides asufficient amount of speech mechanism activity and exercise.

Speech intervention should focus on learning to conserveenergy for priority speaking tasks and to rest often to reducefatigue instead of increasing effort and use with speechexercises. ALS speakers should learn to avoid adverse speak-ing/listening situations by muting the television, invitingpeople to speak with them in a quiet place rather thanin a crowded room, and using voice amplification whenspeaking in noisy environments to reduce the effort required[1, 12]. As speech becomes difficult to understand, manyALS speakers supplement their speech by identifying the firstletter of each word on an alphabet board (alphabet supple-mentation) or by identifying the topic on a communicationboard (topic supplementation). Although improvementsof speech intelligibility have been documented for thesesupplementation procedures in a practice guideline article byHanson et al. [13], none of this research has involved ALSspeakers.

It is often difficult for speakers with ALS, their familymembers and medical personnel to consider AAC strategieswhen they are still using residual speech to meet dailycommunication needs. However, their speaking rate shouldbe clinically monitored such that the referral for an AACintervention is initiated in a timely manner. With sufficienteducation and preparation, people with ALS and theirdecision-makers are ready to examine their AAC options.However, speech deterioration can be so rapid that individ-uals can be left with limited communication options, if theyare not prepared to act in a timely manner.

4. Timely Referral for Communication Support

Often people with ALS, their family members, and, attimes, their medical team, do not wish to consider anAAC decision until their deteriorating speech intelligibilitylimits their communication effectiveness. Unfortunately,once intelligibility begins to decrease, speech performanceoften deteriorates so rapidly that there is little time toimplement an appropriate AAC intervention. Appropriatetiming of referral for AAC assessment and interventioncontinues to be a most important clinical decision-making

issue. Yorkston et al. [8] initially suggested that speaking ratereduction precedes decreases in intelligibility in people withALS. Ball et al. [14, 15] evaluated the speech performanceof 158 different people at 3-month intervals from diagnosisto death. These authors reported that speaking rate is arelatively good predictor of intelligibility deterioration forpatients with spinal, bulbar, or mixed ALS. They recommendthat ALS patients be referred for AAC assessment whentheir speaking rates reach 125 words per minute on theSpeech Intelligibility Test (Sentence Subtest) [16]. The meanspeaking rate on this test for adults without disability is190 words per minute. This computerized test supports theefficient measurement of speaking rate in clinical settings, sospeaking rate information can be shared with the patient andfamily immediately during clinical visits. This helps patientsand their families monitor changes over time, prepare foran AAC evaluation, and it reinforces their understandingof rate and intelligibility. Using the Speech IntelligibilityTest (Sentence Subtest), speaking rate can be accuratelymonitored over the telephone if a patient lives at a distanceor is unable to travel due to illness weather, or supportissues [17]. It should be noted that speech intelligibility couldnot be objectively assessed over the telephone, as a clinicalmeasure of understandability.

Nordness et al. [18] reviewed the records of nearly 300people with ALS served by 3 different AAC centers. Eachof these centers implemented the referral guideline of 125words per minute on the Speech Intelligibility Test (SentenceSubtest). The authors reported that 88% of the people in thesample received timely AAC assessments. “Of the 12% whoreceived “late” referrals, most (93%) were delayed because ofa late referral by their physician, travel demands, and otherinterfering health conditions, while a few (7%) received adelayed assessment because of factors related to the personwith ALS or caregivers.” Most physicians who did not refer ina timely manner were general practitioners, neurologists notassociated with a multidisciplinary neuromuscular clinic, ormedical staff of long-term care facilities. A higher percentageof females than males were identified as receiving late AACassessments.

5. AAC Acceptance

Ball et al. [6] reported that approximately 95% of peoplewith ALS in the Nebraska ALS Database become unable tospeak at some point prior to death. AAC acceptance and usehave increased considerably during the past decade. Priorto 1996, approximately 72% of men and 74% of womenfor whom AAC technology was recommended accepted andused the technology [19]. However, in a more recent reportby Ball et al. [6], 96% of people with ALS for whom speakingrate was monitored and AAC assessment was recommendedin a timely manner accepted and used AAC, with 6% delayingbut eventually accepting the technology. No differences werereported for males and females. In the review by Ball etal. [10] those who rejected AAC reported a cooccurringfunctional dementia or experienced multiple severe healthissues, such as cancer, in addition to ALS.

Page 3: Review Article CommunicationSupportforPeoplewithALS

Neurology Research International 3

AAC acceptance involves the patient with ALS as wellas family members and other caregivers. Richter et al.[20] investigated attitudes toward AAC options by peoplewith ALS, caregivers, and unfamiliar listeners. The resultsindicated agreement among these groups with a strongpreference for AAC use for being over difficult to understandspeech or a low-tech communication book. Fried-Oken et al.[21] surveyed AAC caregivers. They reported very positiveattitudes toward AAC technology. Those with greater AACtechnology skills reported greater rewards associated withcaregiving. They reported increased perception of socialcloseness to the individual with ALS and less difficulty inproviding care.

6. AAC Use

People with ALS use AAC technology for an extended periodof time. Mathy et al. [19] reported on 33 people with ALSbetween 1988 and 1996 and found that the mean durationof use was 14 months. More recent data from the NebraskaALS Database have revealed that people with ALS use theirAAC technology with an average of 24.9 months for thosewith bulbar ALS and 31.1 months for those with spinalALS. Many people used AAC until within a few weeks oftheir deaths. Because 15% of the participants in this studycontinued to use their AAC technology at the time the reportwas completed and were supported by invasive ventilation,the mean duration of use reported likely underestimated thelength of use for this sample and for people with ALS ingeneral [1].

Due to the extended use of AAC with deterioratinglevels of physical control, it is imperative that recommendedtechnology has adjustable access options to meet the rangeof motor capability as the disease progresses, that is, peoplewith ALS should be fitted with AAC technology that supportsmultiple access methods such as allowing them to transitionfrom hand access to scanning and/or head/eye-tracking.Many AAC devices now incorporate a variety of accessoptions so that the technology can continue to meet theneeds of the user despite a decline in physical capability. Thesensitivity of dynamic touch screens can be adjusted to allowfor lighter touch. The improved sensitivity of head-trackingtechnology has allowed many to use this access method withminimal head/neck movement control.

Perhaps the most significant advancement in accesstechnology has occurred with the widespread availabilityof eye-tracking systems to allow cursor control with eyemovement to access high-technology AAC devices. As thedisease progresses, many ALS patients require the use ofeye-tracking for several reasons. First, eye-tracking is oftenthe least fatiguing movement for AAC access. Eye gaze isnatural, and eye muscles generally do not fatigue with use[22, 23]. Compared to other access methods such as switch-activated scanning, eye-tracking is often reported to be theleast fatiguing access method by people with ALS [24].Others have reported that eye-tracking technology requiresrelatively little effort [25, 26]. Second, eye gaze may bethe only volitional movement that the individual continues

to exhibit over time, particularly in cases where invasiveventilation has been chosen [27].

In a follow-up investigation of 15 people with ALS, Ballet al. [27] examined the acceptance, training, and extendeduse patterns of eye-tracking technology to support commu-nication. Ninety-three percent of the participants reportedsuccessful implementation of the technology. For 53% of theparticipants, eye-tracking technology was selected becauseeye movement was the only viable access option available.The one individual who was not able to successfully use eye-tracking technology had difficulty with eyelid control, whichhas been noted as a potential issue in ALS [28].

The communicative functions served by eye-trackingdevices in Ball and colleagues’ [27] investigation wereextensive. All of the participants (100%) used their eye-tracking device to support face-to-face communication.Other functions included group communication (43%),phone (71%), email (79%), and internet (86%). Six ofthe participants (43%) also reported using the eye-trackingtechnology to support other computer-based functions(e.g., word processing, vocation-related software programs).Others have also reported a wide range of communicativefunctions served by AAC for people with ALS [21, 29–31]including word processing, providing accounting services, orconsulting over the phone or Internet.

7. Communication and Life Expectancy

Life expectancy of patients with ALS varies depending ona number of factors. Those who experience initial spinalsymptoms survive approximately five times longer than thosewith initial bulbar (brainstem) symptoms. Life expectancyis longer for those who opt for noninvasive and invasiveventilation than for those who do not [32]. According to adatabase review [33], the decision to use invasive ventilationextends the length of AAC use overall, as well as the durationof time during which AAC technology must be controlledwith minimal or no limb or head movement. Adequatenutrition at the time of diagnosis and artificial nutrition,such as a percutaneous endoscopic gastrostomy (PEG), asthe disease progresses improves the quality of life and mayextend the length of life somewhat [32, 34, 35]. It potentiallycould have an impact on AAC use, in that people withALS who use artificial nutrition spend less time eating, havemore energy, and have more time to participate in the socialactivities of their choice. Often, such participation in socialsituations increases the need and opportunity for AAC use.

8. AAC Training and Support

Training and support are an essential component of AACservice delivery for people with ALS. The significant changesin movement capabilities require that service providers notonly be proactive in their AAC technology recommen-dations by providing technology options that can meetthe changing physical needs over time, but also provideadequate training and support to ensure that the people withALS and their caregivers can successfully implement these

Page 4: Review Article CommunicationSupportforPeoplewithALS

4 Neurology Research International

access strategies over time. Reports of low AAC use oftenaccompany descriptions of minimal training or follow-up[36]. New advances in AAC technology (e.g., eye-tracking)may require a greater amount of training and interventionthan other access options. Ball and colleagues [27] foundthat implementation of eye-tracking systems often requiredtrouble-shooting in the form of physical or environmentalcompensations for successful use of the technology. Forexample, the use of glasses often required adjustments to theLED camera angle to separate the glint on the pupil from theglare on the glasses. Others required environmental lightingchanges (e.g., changing incandescent bulbs to fluorescentlighting, dimming lights, and closing shades). The meanlength of instruction provided for these people was 5 hours(range of 2–20 hours) with a mean troubleshooting time of2.27 hours (range of 0–10 hours).

While AAC specialists are professionals who provide theAAC intervention services such as assessment and initialinstruction, AAC facilitators for people with ALS tend tobe family members who typically provide ongoing supportincluding instruction of new communication partners andcaregivers, programming new messages into the AAC device,maintaining the AAC system, and interacting with thetechnology manufacturer if necessary [37]. Ball et al. [38]surveyed 68 people with ALS who used AAC technology.All identified a primary AAC facilitator. Ninety-six percentof the AAC facilitators were family members, most withnontechnical backgrounds. In response to a survey, theseprimary facilitators preferred hands-on, detailed step-by-step instruction. They reported receiving slightly over 2hours of instruction and reported that amount of trainingas appropriate.

9. Future Research Directions

Although not documented with published research findings,AAC service delivery models for people with ALS differconsiderably. The Nebraska Database was collected froma highly integrated intervention system in which a speechlanguage pathologist with considerable AAC expertise isa regular staff member in three regional clinics that alsoincludes a neurologist, physical therapist, occupational ther-apist, registered dietitian, respiratory therapist, and socialworker. This AAC interventionist provides routine speechscreening and education with families. When the speakingrate threshold of 125 words per minute on the SpeechIntelligibility Test (Sentence Subtest) is reached, ALS patientsare referred to one of three AAC specialty programs forassessment, implementation, and follow-up. The acceptanceand use data for each patient are reported back to thecoordinating AAC specialist involved in the AAC clinics.This process typically provides a gradual familiarizationwith AAC, which reflects a process reported to increaseadaptation to or acceptance of other supports, such asassisted ventilation [39]. On the other hand, the Murphy[36] article documents AAC acceptance and usage associatedwith a much less integrated service delivery system. Theauthors suggest that the organization of the service deliverysystem may have impacted the AAC acceptance and use data

reported in this study. Research is needed to investigate theimpact of AAC service delivery strategies on interventioneffectiveness.

The impact of cognitive function on AAC acceptance anduse needs to be investigated systematically. Ball et al. [1]note that while the prevalence of cognitive impairments inpeople with ALS is more common than previously thought,these impairments seem to influence AAC acceptance anduse in a relatively small percentage of those with ALS. Aswas reported earlier in this paper, a limited number ofAAC patients with severe frontotemporal dementia rejectedAAC intervention. A recent research summary has reportedthat between 10–75% of ALS patients experience cognitiveimpairment and between 15–41% experience a fronto-temporal dementia (FTD) as measured by neuropsycholog-ical testing, although its effect on management of ALS isunknown [40]. In preparation for this paper the authorsreviewed the Nebraska Database for the ALS patients servedin the last 30 months (N = 87). According to themultidisciplinary clinical screen, 77.0% did not demonstratecognitive impairments, 18.4% demonstrated a mild cognitiveimpairment, and 4.6% demonstrated a fronto-temporaldementia (FTD). Of the patients with FTD, two were notcapable of using AAC, one was able to write and gesture,and one was still able to use some speech. Of the patientswith a mild cognitive impairment, 62.5% (N = 10) wereable to communicate with AAC, 25% (N = 4) did not yetrequire AAC, and 12.5% (N = 2) rejected AAC. Anecdotally,the authors supported numerous patients with ALS whosecognitive limitations were of concern to the ALS clinic team,but who accepted and used high- and low-technology AACstrategies successfully to meet their communication needs.Research is needed to objectively document AAC acceptanceand use related primarily to cognitive impairment. Furtherresearch is also needed to clarify the level of cognitiveimpairment that tends to interfere with AAC intervention.

Brain computer interface (BCI) technology has generatedconsiderable research interest for people who are physically“locked-in” such as those in the late stages of ALS. BCIresearch includes invasive (implantable electrodes on or inthe neocortex) and noninvasive means (including electroen-cephalography (EEG), magnetoencephalography (MEG),fMRI, and the less expensive near-infrared spectography(NIRS)). Non-invasive methods have been utilized moreextensively than invasive methods for people with disabilities(such as those with ALS) [41–43]. While those with ALSand other conditions who are in a “locked-in” physical statehave motivated research in this area, very few systems havebeen successful with this population. It has been postulatedthat some forms of cognitive impairment and changes inEEG signatures in late stage ALS may contribute to thelack of success using BCI technology as the technology wasintroduced after the participants had become “locked-in”[41, 44]. The most successful application for communicationhas occurred in people at the beginning stages of the disease[45–47]. To date, no investigations have reported of theuse of BCI throughout the disease progression of ALS todetermine if these people would be able to maintain trainingand functional of the systems.

Page 5: Review Article CommunicationSupportforPeoplewithALS

Neurology Research International 5

Use of AAC interventions, including speech generatingdevices, is recognized as the standard of care (practice) forpeople with speech-related functional losses associated withALS. Considerable research has documented the need forAAC support, as well as the acceptance, use, and effectivenessof AAC strategies for people with this medical diagnosis. Asin other fields, additional research is needed to develop newintervention strategies and to document their effectiveness.

Acknowledgments

The preparation of this paper was supported in partby The Rehabilitation Engineering Research Center onCommunication Enhancement (AAC-RERC) funded underGrant no.H133E080011 from the National Institute onDisability and Rehabilitation Research (NIDRR) in the U.S.Department of Education’s Office of Special Educationand Rehabilitative Services (OSERS), the Barkley Trust, theMunroe-Meyer Institute of Genetics and Rehabilitation, andMadonna Rehabilitation Hospital. The authors report noconflicts of interest. The authors alone are responsible for thecontent and writing of the paper.

References

[1] L. Ball, D. Beukelman, and L. Bardach, “AAC interventionfor ALS,” in Augmentative Communication Strategies for Adultswith Acute or Chronic Medical Conditions, D. Beukelman, K.Garrett, and K. Yorkston, Eds., pp. 287–316, Paul H. Brookes,Baltimore, Md, USA, 2007.

[2] D. Beukelman and P. Mirenda, Augmentative and AlternativeCommunication: Supporting Children Adults with ComplexCommunication Needs, Paul H. Brookes, Baltimore, Md, USA,2005.

[3] F. L. Darley, A. E. Aronson, and J. R. Brown, “Clusters ofdeviant speech dimensions in the dysarthrias,” Journal ofSpeech and Hearing Research, vol. 12, no. 3, pp. 462–496, 1969.

[4] J. Duffy, Motor Speech Disorders: Substrates, Differential Diag-nosis, and Management, Elsevier Mosby, St. Louis, Mo, USA,2nd edition, 2005.

[5] K. M. Yorkston, R. M. Miller, and E. A. Strand, Management ofSpeech and Swallowing Disorders in Degenerative Disease, Pro-Ed, Austin, Tex, USA, 2nd edition, 2004.

[6] L. J. Ball, D. R. Beukelman, and G. L. Pattee, “Acceptance ofaugmentative and alternative communication technology bypersons with amyotrophic lateral sclerosis,” Augmentative andAlternative Communication, vol. 20, no. 2, pp. 113–122, 2004.

[7] M. Nishio and S. Niimi, “Changes over time in dysarthricpatients with amyotrophic lateral sclerosis (ALS): a studyof changes in speaking rate and maximum repetition rate(MRR),” Clinical Linguistics and Phonetics, vol. 14, no. 7, pp.485–497, 2000.

[8] K. Yorkston, E. Strand, R. Miller, A. Hillel, and K. Smith,“Speech deterioration in amyotrophic lateral sclerosis: impli-cations for the timing of intervention,” Journal of MedicalSpeech-Language Pathology, vol. 1, no. 1, pp. 35–46, 1993.

[9] Y. Yunusova, J. R. Green, M. J. Lindstrom, L. J. Ball, G. L.Pattee, and L. Zinman, “Kinematics of disease progression inbulbar ALS,” Journal of Communication Disorders, vol. 43, no.1, pp. 6–20, 2010.

[10] L. J. Ball, D. R. Beukelman, and G. L. Pattee, “Communicationeffectiveness of individuals with amyotrophic lateral sclerosis,”Journal of Communication Disorders, vol. 37, no. 3, pp. 197–215, 2004.

[11] E. Hanson, K. Yorkston, and D. Britton, “Dysarthria in amy-otrophic lateral sclerosis: a systematicreview of characteristics,speech treatment, and AAC options,” Journal of Medical SpeechLanguage Pathology. In press.

[12] K. Yorkston, D. Beukelman, E. Strand, and M. Hakel, Manage-ment of Motor Speech Disorders in Children and Adults, Pro-Ed,Austin, Tex, USA, 2010.

[13] E. K. Hanson, K. M. Yorkston, and D. R. Beukelman,“Speech supplementation techniques for dysarthria: a system-atic review,” Journal of Medical Speech-Language Pathology,vol. 12, no. 2, pp. 9–29, 2004.

[14] L. J. Ball, A. Willis, D. R. Beukelman, and G. L. Pattee, “Aprotocol for identification of early bulbar signs in amyotrophiclateral sclerosis,” Journal of the Neurological Sciences, vol. 191,no. 1-2, pp. 43–53, 2001.

[15] L. J. Ball, D. R. Beukelman, and G. L. Pattee, “Timing of speechdeterioration in people with amyotrophic lateral sclerosis,”Journal of Medical Speech-Language Pathology, vol. 10, no. 4,pp. 231–235, 2002.

[16] K. Yorkston, D. Beukelman, M. Hakel, and M. Dorsey,Sentence Intelligibility Test, Speech Intelligibility Test, MadonnaRehabilitation Hospital, Lincoln, Neb, USA, 2007.

[17] L. J. Ball, D. R. Beukelman, C. Ullman, K. Maassen, and G.L. Pattee, “Monitoring speaking rate by telephone for personswith amyotrophic lateral sclerosis,” Journal of Medical Speech-Language Pathology, vol. 13, no. 4, pp. 233–240, 2005.

[18] A. Nordness, L. Ball, S. Fager, D. Beukelman, and G. Pattee,“Late AAC assessment for individuals with amyotrophic lateralsclerosis,” Journal of Medical Speech Language Pathology, vol.18, pp. 48–54, 2010.

[19] P. Mathy, K. Yorkston, and M. Gutmann, “AAC for individualswith amyotrophic lateral sclerosis,” in Augmentative andAlternative Communication for Adults with Acquired NeurologicDisorders, D. Beukelman, K. Yorkston, and J. Reichle, Eds., pp.183–231, Paul H. Brookes, Baltimore, Md, USA, 2000.

[20] M. Richter, L. Ball, D. Beukelman, J. Lasker, and C. Ullman,“Attitudes toward three communication modes used by per-sons with amyotrophic lateral sclerosis for storytelling to asingle listener,” Augmentative and Alternative Communication,vol. 19, pp. 170–186, 2003.

[21] M. Fried-Oken, L. Fox, M. T. Rau et al., “Purposes of AACdevice use for persons with ALS as reported by caregivers,”Augmentative and Alternative Communication, vol. 22, no. 3,pp. 209–221, 2006.

[22] R. Bates and H. Istance, “Why are eye mice unpopular? Adetailed comparison of head and eye controlled assistive tech-nology pointing devices,” Universal Access in the InformationSociety, vol. 2, pp. 280–290, 2003.

[23] A. Hyrskykari, P. Majaranta, and K.-J. Raiha, “From gazecontrol to attentive interfaces,” in Proceedings of the HCII, LasVegas, Nev, USA, 2005.

[24] C. Gibbons and E. Beneteau, “Functional performance usingeye control and single switch scanning by people with ALS,”Perspectives on Augmentative and Alternative Communication,vol. 19, no. 3, pp. 64–69, 2010.

[25] A. Calvo, A. Chio, E. Castellina et al., “Eye tracking impact onquality-of-life of ALS patients,” in Proceedings of the Conferenceon Computers Helping People with Special Needs, vol. 5101 ofLecture Notes in Computer Science, pp. 70–77, 2008.

Page 6: Review Article CommunicationSupportforPeoplewithALS

6 Neurology Research International

[26] D. Harris and M. Goren, “The ERICA eye gaze system versusmanual letter board to aid communication in ALS/MND,”British Journal of Neuroscience Nursing, vol. 5, no. 5, pp. 227–230, 2009.

[27] L. Ball, A. Nordness, S. Fager et al., “Eye-gaze access of AACtechnology for persons with amyotrophic lateral sclerosis,”Journal Medical Speech Language Pathology, vol. 18, pp. 11–23,2010.

[28] M. Ohki, R. Kanayama, T. Nakamura, T. Okuyama, Y. Kimura,and Y. Koike, “Ocular abnormalities in amyotrophic lateralsclerosis,” Acta Oto-Laryngologica, no. 511, supplement, pp.138–142, 1994.

[29] M. Doyle and B. Phillips, “Trends in augmentative and alter-native communication use by individuals with amyotrophiclateral sclerosis,” Augmentative and Alternative Communica-tion, vol. 17, no. 3, pp. 167–178, 2001.

[30] D. McNaughton, J. Light, and L. Groszyk, ““Don’t give up”:employment experiences of individuals with amyotrophiclateral sclerosis who use augmentative and alternative commu-nication,” Augmentative and Alternative Communication, vol.17, no. 3, pp. 179–194, 2001.

[31] D. McNaughton and D. N. Bryen, “Enhancing participation inemployment through AAC technologies,” Assistive Technology,vol. 14, no. 1, pp. 58–70, 2002.

[32] R. G. Miller, C. E. Jackson, E. J. Kasarskis et al., “Practiceparameter update: the care of the patient with amyotrophiclateral sclerosis: drug, nutritional, and respiratory therapies(an evidence-based review): report of the quality standardssubcommittee of the American academy of neurology,” Neu-rology, vol. 73, no. 15, pp. 1218–1226, 2009.

[33] L. J. Ball, D. R. Beukelman, E. Anderson, D. V. Bilyeu, J.Robertson, and G. L. Pattee, “Duration of AAC technologyuse by persons with ALS,” Journal of Medical Speech-LanguagePathology, vol. 15, no. 4, pp. 371–381, 2007.

[34] R. Haughty, J. Johnson, and C. Campbell, “Empoweringpeople with motor neuron disease to make informed decisionsabout life prolonging treatments,” in Proceedings of theInternational Symposium on ALS/MND, Allied ProfessionalsForum, 2005.

[35] N. Limousin, H. Blasco, P. Corcia et al., “Malnutrition at thetime of diagnosis is associated with a shorter disease durationin ALS,” Journal of the Neurological Sciences, vol. 297, no. 1-2,pp. 36–39, 2010.

[36] J. Murphy, ““I prefer contact this close”: perceptions of AAC bypeople with motor neurone disease and their communicationpartners,” Augmentative and Alternative Communication, vol.20, no. 4, pp. 259–271, 2004.

[37] D. R. Beukelman, L. J. Ball, and S. Fager, “An AAC personnelframework: adults with acquired complex communicationneeds,” Augmentative and Alternative Communication, vol. 24,no. 3, pp. 255–267, 2008.

[38] L. Ball, K. Schardt, and D. Beukelman, “Primary communica-tion facilitators,” Augmentative Communication News, vol. 17,pp. 6–7, 2005.

[39] J. Lemoignan and C. Ells, “Amyotrophic lateral sclerosisand assisted ventilation: how patients decide,” Palliative andSupportive Care, vol. 8, no. 2, pp. 207–213, 2010.

[40] R. G. Miller, C. E. Jackson, E. J. Kasarskis et al., “PracticeParameter update: the care of the patient with amyotrophiclateral sclerosis: multidisciplinary care, symptom manage-ment, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommitteeof the American Academy of Neurology,” Neurology, vol. 73,no. 15, pp. 1227–1233, 2009.

[41] M. V. Gerven, J. Farquhar, R. Schaefer et al., “The brain-computer interface cycle,” Journal of Neural Engineering, vol.6, no. 4, pp. 1–10, 2009.

[42] N. Birbaumer and L. G. Cohen, “Brain-computer interfaces:communication and restoration of movement in paralysis,”Journal of Physiology, vol. 579, no. 3, pp. 621–636, 2007.

[43] N. Birbaumer, A. R. Murguialday, and L. Cohen, “Brain-computer interface in paralysis,” Current Opinion in Neurol-ogy, vol. 21, no. 6, pp. 634–638, 2008.

[44] T. F. Munte, M. C. Troger, I. Nusser et al., “Alteration of earlycomponents of the visual evoked potential in amyotrophiclateral sclerosis,” Journal of Neurology, vol. 245, no. 4, pp. 206–210, 1998.

[45] N. Birbaumer, N. Ghanayim, T. Hinterberger et al., “A spellingdevice for the paralysed,” Nature, vol. 398, no. 6725, pp. 297–298, 1999.

[46] A. Kubler, N. Neumann, J. Kaiser, B. Kotchoubey, T. Hinter-berger, and N. P. Birbaumer, “Brain-computer communica-tion: self-regulation of slow cortical potentials for verbal com-munication,” Archives of Physical Medicine and Rehabilitation,vol. 82, no. 11, pp. 1533–1539, 2001.

[47] N. Birbaumer, “Brain-computer-interface research: coming ofage,” Clinical Neurophysiology, vol. 117, no. 3, pp. 479–483,2006.

Page 7: Review Article CommunicationSupportforPeoplewithALS

Submit your manuscripts athttp://www.hindawi.com

Stem CellsInternational

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

MEDIATORSINFLAMMATION

of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Behavioural Neurology

EndocrinologyInternational Journal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Disease Markers

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

BioMed Research International

OncologyJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Oxidative Medicine and Cellular Longevity

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

PPAR Research

The Scientific World JournalHindawi Publishing Corporation http://www.hindawi.com Volume 2014

Immunology ResearchHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Journal of

ObesityJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Computational and Mathematical Methods in Medicine

OphthalmologyJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Diabetes ResearchJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Research and TreatmentAIDS

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Gastroenterology Research and Practice

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Parkinson’s Disease

Evidence-Based Complementary and Alternative Medicine

Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com